No abstract available
MeSH terms
-
Aged
-
Cost-Benefit Analysis
-
Drug Costs
-
Fractures, Bone / prevention & control
-
Humans
-
Middle Aged
-
Models, Economic*
-
Osteoporosis / drug therapy
-
Osteoporosis / economics*
-
Program Evaluation
-
Quality-Adjusted Life Years
-
Risk Assessment
-
Treatment Outcome